Search
Now showing items 1-10 of 24
Postprandial hyperglycemia: Why do we care about it? What should we do?
Rendell, M. S. Postprandial hyperglycemia: Why do we care about it? What should we do? Drug Development Research. 2006, JUL. 67(7):582-586.
Targeting postprandial hyperglycemia
Rendell, M. S. and Jovanovic, L. Targeting postprandial hyperglycemia. Metabolism-Clinical and Experimental. 2006, SEP. 55(9):1263-1281.
Metabolic syndrome: A wake-up call
Rendell, M. and Gurwitz, D. Metabolic syndrome: A wake-up call. Drug Development Research. 2006, JUL. 67(7):535-538.
Pioglitazone
Rendell, M. Pioglitazone. Drugs. 2006, . 66(14):1879-1880.
Effects of the Dipeptidyl Peptidase-IV Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects With Impaired Glucose Tolerance
Rosenstock, Julio; Foley, James E.; Rendell, Marc; Landin-Olsson, Mona; Holst, Jens J.; Deacon, Carolyn F.; Rochotte, Erika; Baron, Michelle A. Effects of the Dipeptidyl Peptidase-IV Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects With Impaired Glucose Tolerance. Diabetes care. 2008, 01. 31(1):30-35.
A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes
Sutton, MS; Rendell, M.; Dandona, P.; Dole, JF; Murphy, K.; Patwardhan, R.; Patel, J.; Freed, M.; Rosiglitazone Clin Trials Study Gr. A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes care. 2002, NOV. 25(11):2058-2064.
Skin blood flow in diabetic dermopathy
Wigington, G.; Ngo, B.; Rendell, M. Skin blood flow in diabetic dermopathy. Archives of Dermatology. 2004, OCT. 140(10):1248-1250.
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1c) without causing weight gain or increased hypoglycaemia
Rosenstock, J.; Rendell, M. S.; Gross, J. L.; Fleck, P. R.; Wilson, C. A.; Mekki, Q. Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1c) without causing weight gain or increased hypoglycaemia. Diabetes Obesity & Metabolism. 2009, DEC. 11(12):1145-1152.
Depressed ventilatory reflexes after capsaicin challenge in streptozotocin-treated rats
Bergren, Dale R. and Rendell, Marc S. Depressed ventilatory reflexes after capsaicin challenge in streptozotocin-treated rats. Life Sciences. 2004, 9/10. 75(17):2103-2116.
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial
Apfel, SC; Schwartz, S.; Adornato, BT; Freeman, R.; Biton, V.; Rendell, M.; Vinik, A.; Giuliani, M.; Stevens, JC; Barbano, R.; Dyck, PJ; rhNGF Clin Investigator Grp. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy - A randomized controled trial. Jama-Journal of the American Medical Association. 2000, NOV 1. 284(17):2215-2221.